Differentiating Benign and Malignant Breast Lesions with T2*-Weighted First Pass Perfusion Imaging

References

• Aronen H. J., Gazit I. E., Louis D. N., et al. Cerebral blood volume maps of gliomas. Comparison with tumor grade and histologic findings. Radiology 1994; 191: 41
   PubMed Web of Science ®Google Scholar
• Boetes C., Barentsz J. O., Mus R. D., et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced turbo-FLASH subtraction technique. Radiology 1994; 193: 777
   PubMed Web of Science ®Google Scholar
• Boné B., Aspelin P., Bronge L., Isberg B., Perbeck L., Veress B. Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 1996; 37: 208
   PubMed Web of Science ®Google Scholar
• Boné B., Pentek Z., Perbeck L., Veress B. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997; 38: 489
   PubMed Web of Science ®Google Scholar
• Buadu L. A., Murakami J., Murayama S., et al. Breast lesions. Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angionesis. Radiology 1996; 200: 639
   PubMed Web of Science ®Google Scholar
• Fischer U. V., Heyden D. V., Vosshenrich R., et al. Signal/time relation of benign and malignant lesions in dynamic 2D-MR imaging of the breast. RÖFO 1993; 158: 287
   PubMedGoogle Scholar
• Flickinger F. W., Allison J. D., Sherry R. M., et al. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn. Reson. Imaging 1993; 11: 617
   PubMed Web of Science ®Google Scholar
• Folkman J., Shing Y. Angiogenesis. J. Biol. Chem 1992; 267: 10931
   PubMed Web of Science ®Google Scholar
• Frouge C., Guinebretiere J. M., Contesso G., et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of breast and tumor angiogenesis. Invest. Radiol 1994; 29: 1043
   PubMed Web of Science ®Google Scholar
• Gilles R., Garnier C., Meingan P., et al. Fibroadenomas of the breast. Histopathological/dynamic contrast-enhanced MR correlation. Eur. Radiol 1995; 5: 511
   Web of Science ®Google Scholar
• Gilles R., Meunier M., Lucidarme O., et al. Clustered breast calcifications. Evaluation by dynamic contrast-enhanced subtraction MRI. J. Comput. Assist. Tomogr 1996; 20: 9
   PubMed Web of Science ®Google Scholar
• Greenstein S. Orel, Schnall M. D., LiVolsi V. A., Troupin R. H. Suspicious breast lesions. MR imaging with radiologic-pathologic correlation. Radiology 1994; 190: 485
   PubMed Web of Science ®Google Scholar
• Gribbestad I. S., Nilsen G., Fjøsne H., et al. Contrast-enhanced magnetic resonance imaging of the breast. Acta Oncol 1992; 31: 833
   PubMed Web of Science ®Google Scholar
• Griebel J., Mayr N. A., de Vries A., et al. Assessment of tumor microcirculation - a new role of dynamic contrast MR imaging. J. Magn. Reson. Imaging 1997; 7: 111
   PubMed Web of Science ®Google Scholar
• Harms S. E., Flamig D. P., Hesley K. L., et al. MR imaging of the breast with rotating delivery of excitation off resonance. Clinical experience with pathologic correlation. Radiology 1993; 187: 493
   PubMed Web of Science ®Google Scholar
• Heywang S. H., Wolf A., Pruss E., et al. MR imaging of the breast with Gd-DTPA. Use and limitations. Radiology 1989; 171: 95
   PubMed Web of Science ®Google Scholar
• Hulka C. A., Smith B. L., Sgroi D. C., et al. Benign and malignant breast lesions. Differentiation with echo-planar MR imaging. Radiology 1995; 197: 33
   PubMed Web of Science ®Google Scholar
• Kaiser W. A. MR imaging promises earlier breast cancer diagnosis. Diagn. Imaging Int 1992; 8: 88
   Google Scholar
• Kessler M. Debate grows over breast imagings future. Diagn. Imaging Eur 1997; 13: 49
   Google Scholar
• Kuhl C. K., Bieling H., Gieseke J., et al. Breast neoplasms. T2* susceptibility-contrast, first pass perfusion MR imaging. Radiology 1997; 202: 87
   PubMed Web of Science ®Google Scholar
• Kuhl C. K., Bieling H. B., Gieseke J., et al. Healthy pre-menopausal breast parenchyma in dynamic contrast enhanced MR imaging of the breast. Normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997; 203: 137
   PubMed Web of Science ®Google Scholar
• Müller-Schimpfle M., Stoll P., Stern W., et al. Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography. AJR 1997; 168: 1323
   PubMed Web of Science ®Google Scholar
• Rempp K. A., Brix G., Wenz F., et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193: 637
   PubMed Web of Science ®Google Scholar
• Rinck P. A. Some future perspectives of contrast agent development. Clin. MRI 1995; 5: 129
   Google Scholar
• Sorensen A. G., Tievsky A. L., Ostergaard L., et al. Contrast agents in functional MR imaging. J. Magn. Reson. Imaging 1997; 7: 47
   PubMed Web of Science ®Google Scholar
• Stomper P. C., Herman S., Klippenstein D. L., et al. Suspect breast lesions. Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197: 387
   PubMed Web of Science ®Google Scholar
• Su S., Shen J., Tian G., et al. A reevaluation of T1- and T2*-weighted imaging methods for myocardial perfusion. Proc. Soc. Magn. Reson. 1995, Berkeley, CA, 1996, (Abstract, p. 684.)
   Google Scholar
• Van Duke C. F., Brasch R. C., Roberts T. P. L., et al. Mammary carcinoma model - correlation of macromolec-ular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996; 198: 813
   PubMed Web of Science ®Google Scholar